http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201992690-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
filingDate 2018-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201992690-A1
titleOfInvention APPLICATION OF VIBEGRON FOR TREATMENT OF A HYPERACTIVE BLADDER
abstract The invention relates to a method for treating an overactive bladder, comprising orally administering to a subject in need thereof a vibegron in an amount of from about 60 to about 90 mg (e.g., about 75 mg) per day. The present invention also relates to a pharmaceutical composition in unit dosage form containing from about 60 to about 90 mg (e.g., about 75 mg) of vibegron for oral administration.
priorityDate 2018-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44472635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413592487

Total number of triples: 23.